Balyasny Asset Management »

Peregrine Pharmaceuticals shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 112k 11.38
2024-06-30 $241k 34k 7.14
2023-09-30 $265k 28k 9.44
2023-06-30 $2.7M 193k 13.97
2021-03-31 $1.4M 77k 18.24
2020-12-31 $2.9M 250k 11.54